MDNews - Cleveland-Akron-Canton

November/December 2015

Issue link: http://viewer.e-digitaledition.com/i/589857

Contents of this Issue

Navigation

Page 24 of 43

2 0 1 5 N OV E M B E R / D E C E M B E R ■ M D N E W S . CO M ■ MD NEWS Cleveland/Akron/Canton | 2 5 Multiple Services With A Single Focus: Your Success © Copyright 2015. CBIZ, Inc. NYSE Listed: CBZ. All rights reserved. 4040 Embassy Parkway, Suite 100 • Akron, OH 44333 Martha Bethea • Christina Burr 330.668.6500 • www.cbiz.com n Efciency reengineering n Financing structure and negotiations n Reimbursement methodologies – risk sharing – bundle payment n Structure for related businesses n Medical practice merger, acquisition, integration n Financial statement preparation and analysis T CELLS FROM PATIENTS with melanoma can trigger a protective immune response against the disease, according to a new study out of University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine. P ublished in t he Ju ly/Aug ust issue of Jour nal of Immunotherapy, these new findings demonstrate that T cells derived from lymph nodes of patients with melanoma can be expanded in number and activated in the laboratory for intravenous administration in the treatment of patients. Led by Julian Kim, MD, Chief Medical Officer at UH Seidman Cancer Center, the research team has developed a novel technique to generate large numbers of activated T cells which can be transferred back into the same patient to stimulate the immune system to attack the cancer. "This study is unique in that the source of T cells for therapy is derived from the lymph node, which is the natural site of the immune response against pathogens as well as cancer," says Dr. Kim, who is also Professor of Surgery at Case Western Reserve University School of Medicine and the Charles Hubay Chair at UH Case Medical Center. "These encouraging results provide the rationale to start testing the transfer of activated T cells in a human clinical trial." ■ Advanced Melanoma Activated T Cell Therapy Developed for +++++++++++++++++++++++++ +++ + +++ + +++++++++++++++++++++++++ ❮ RECENT RESEARCH

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - November/December 2015